https://www.selleckchem.com/pr....oducts/nsc697923.htm
Approximately 50% of cancer patients eventually develop a syndrome of prolonged weight loss(cachexia), which may contribute to primary resistance to immune checkpoint inhibitors(ICI). This study utilised radiomics analysis of F-FDG-PET/CT images to predict risk of cachexia that can be subsequently associated with clinical outcomes among advanced non-small cell lung cancer(NSCLC) patients treated with ICI. Baseline(pre-therapy) PET/CT images and clinical data were retrospectively curated from 210 ICI-treated NSCLC patients from two ins
Aimer
Commentaire
Partagez
